Zerodol-SP vs Chymoral Forte: Enzymatic Anti-inflammatory Swelling Comparison
Detailed clinical comparison of Zerodol-SP (Aceclofenac + Paracetamol + Serratiopeptidase) vs Chymoral Forte (Trypsin + Chymotrypsin): post-surgical...
Zerodol-SP combines two painkillers (Aceclofenac + Paracetamol) with one proteolytic enzyme (Serratiopeptidase 15mg) to simultaneously kill pain and reduce swelling. Chymoral Forte contains pure proteolytic enzymes (Trypsin-Chymotrypsin 100,000 AU) without any painkiller, focusing solely on dissolving blood clots (hematomas), reducing tissue edema, and accelerating surgical wound healing.
1. Pain Relief vs Pure De-swelling Action
If a patient suffers from intense throbbing pain alongside swelling (such as a fresh fracture or severe tooth extraction), Zerodol-SP directly blocks prostaglandin pain signals. If swelling, bruising, or blood pooling (hematoma) is the primary issue without severe pain, Chymoral Forte resolves tissue inflammation without NSAID stomach side effects.
2. Administration Differences (Empty Stomach vs After Food)
Zerodol-SP contains NSAIDs and MUST be taken AFTER food. Conversely, Chymoral Forte enteric-coated tablets should be swallowed on an EMPTY STOMACH (30 minutes before meals) so the enzymes pass directly into the blood without digesting dietary proteins.
3. Generic Alternative & Price Analysis
Branded Zerodol-SP costs ~₹125 for 10 tablets; Chymoral Forte costs ~₹520 for a strip of 20 tablets. Generic bioequivalent formulations at Jan Aushadhi cost up to 75-80% less.
Top 8 Essential Indian Medicines: Branded MRP vs. Jan Aushadhi Generic Comparison
Compare average Indian retail MRP of top branded formulations against government-certified PMBJP Jan Aushadhi bioequivalent generic prices and active salts. Verified against official PMBJP formularies, NPPA price caps, and CDSCO regulatory registries.
| Brand Name | Leading Manufacturer | Active Salt Formulation (IP) | Branded MRP | Jan Aushadhi Price | Savings % |
|---|---|---|---|---|---|
| Augmentin 625 Duo | GlaxoSmithKline Pharmaceuticals | Amoxicillin Trihydrate 500mg + Potassium Clavulanate 125mg IP | ₹220.00 | ₹58.00 | 74% |
| Dolo 650 | Micro Labs Ltd | Paracetamol (Acetaminophen) 650mg IP | ₹34.00 | ₹5.50 | 84% |
| Pantocid 40 | Sun Pharmaceutical Industries | Pantoprazole Sodium 40mg IP (Gastro-resistant) | ₹155.00 | ₹8.00 | 95% |
| Azithral 500 | Alembic Pharmaceuticals | Azithromycin Dihydrate 500mg IP | ₹132.00 | ₹24.00 | 82% |
| Glycomet 500 | USV Private Limited | Metformin Hydrochloride 500mg IP | ₹24.00 | ₹4.50 | 81% |
| Shelcal 500 | Torrent Pharmaceuticals | Elemental Calcium 500mg + Cholecalciferol (Vit D3) 250 IU IP | ₹134.00 | ₹16.00 | 88% |
| Telma 40 | Glenmark Pharmaceuticals | Telmisartan 40mg IP | ₹92.00 | ₹7.50 | 92% |
| Montair-LC | Cipla Ltd | Montelukast Sodium 10mg + Levocetirizine Dihydrochloride 5mg IP | ₹210.00 | ₹18.00 | 91% |
| Combined 8-Drug Essential Therapy Basket Total: | ₹1,001.00 | ₹141.00 | 85.9% Net Savings | ||
Frequently Asked Questions (Clinical & Regulatory)
Q1: Can Zerodol-SP and Chymoral Forte be taken together?
Orthopedic surgeons occasionally combine both for massive orthopedic trauma, but always under strict surgical supervision to monitor bleeding parameters.
Q2: Can Chymoral Forte cause allergic reactions?
Rare hypersensitivity reactions can occur with systemic proteolytic enzymes; discontinue if an itchy rash develops.
Q3: How does the CDSCO define bioequivalence when comparing two pharmaceutical formulations?
Bioequivalence is confirmed when two pharmaceutical products contain identical active therapeutic moieties and show no statistically significant difference in Cmax and AUC under single-dose fasting and fed pharmacokinetic studies within the 80% to 125% confidence interval.
Q4: When comparing two drugs in the same clinical class, what determines superior therapeutic choice?
Therapeutic selection depends on receptor selectivity, onset speed, elimination half-life, clearance pathway (hepatic CYP450 vs renal excretion), drug interaction liability, and clinical trial evidence regarding organ-specific outcomes.
Q5: Can patients interchange two bioequivalent branded formulations without loss of efficacy?
Yes. Formulations produced under Schedule M Good Manufacturing Practices containing identical active pharmaceutical salts and dissolution profiles can be interchanged safely under pharmacist guidance.
This clinical guide is authored and reviewed in accordance with the regulatory standards of the Indian Pharmacopoeia (IP), Central Drugs Standard Control Organization (CDSCO) drug schedules, and Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) bioequivalence guidelines. All therapeutic recommendations and drug interaction warnings are cross-referenced with official statutory publications.
Under India's Digital Personal Data Protection (DPDP) Act, 2023, MediMatch AI functions as a data fiduciary committed to zero retention of private health identifiers. Browsing educational guides, reviewing active salt monographs, and executing search queries occur without tracking or commercial profiling. All client interactions with prescription readers or lab decoders execute ephemerally in volatile memory with zero server-side storage of protected health information (PHI). For inquiries regarding data fiduciary obligations, contact our Data Protection Officer at privacy@medimatchai.in.